Cargando…

Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection

Chronic hepatitis B affects more than 250 million individuals worldwide, putting them at risk of developing liver cirrhosis and liver cancer. While antiviral immune responses are key to eliminating hepatitis B virus (HBV) infections, insufficient antiviral immunity characterized by failure to elimin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knolle, Percy A., Huang, Li-Rung, Kosinska, Anna, Wohlleber, Dirk, Protzer, Ulrike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623083/ https://www.ncbi.nlm.nih.gov/pubmed/34835264 http://dx.doi.org/10.3390/vaccines9111333

Ejemplares similares

Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection
por: Kosinska, Anna D., et al.
Publicado: (2019)

The role of liver sinusoidal cells in local hepatic immune surveillance
por: Wohlleber, Dirk, et al.
Publicado: (2016)

Therapeutic Vaccination in Chronic Hepatitis B: Preclinical Studies in the Woodchuck
por: Kosinska, Anna D., et al.
Publicado: (2010)

Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection
por: Kosinska, Anna D., et al.
Publicado: (2021)

PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B
por: Bunse, Till, et al.
Publicado: (2022)

Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck
por: Kosinska, Anna D., et al.
Publicado: (2014)

Design of therapeutic vaccines: hepatitis B as an example
por: Kutscher, Sarah, et al.
Publicado: (2012)

Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B
por: Klopp, Alexandre, et al.
Publicado: (2021)

In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity
por: Manske, Katrin, et al.
Publicado: (2021)

Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24(high)CD38(high) Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders
por: Körber, Nina, et al.
Publicado: (2021)

Control of Hepatitis B Virus by Cytokines
por: Xia, Yuchen, et al.
Publicado: (2017)

Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance
por: Sacherl, Julia, et al.
Publicado: (2022)

Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes
por: Esser, Knud, et al.
Publicado: (2023)

Immunological functions of liver sinusoidal endothelial cells
por: Knolle, Percy A, et al.
Publicado: (2016)

Vaccination against Hepatitis B: A Scoping Review
por: Mohanty, Parimala, et al.
Publicado: (2020)

Vaccination at the forefront of the fight against hepatitis B and C
por: El-Sayed, Manal H., et al.
Publicado: (2021)

IFN-α-mediated Base Excision Repair Pathway Correlates with Antiviral Response Against Hepatitis B Virus Infection
por: Li, Yong, et al.
Publicado: (2017)

Should dermatologists be immunized against hepatitis B?
por: Smith, J. Graham, et al.
Publicado: (1983)

Immune therapies against chronic hepatitis B
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2022)

Insights into induction of the immune response by the hepatitis B vaccine
por: Di Lello, Federico Alejandro, et al.
Publicado: (2022)

Inactivated Orf Virus Shows Antifibrotic Activity and Inhibits Human Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Replication in Preclinical Models
por: Paulsen, Daniela, et al.
Publicado: (2013)

Impact of Universal Vaccination Against Hepatitis B: The Italian Model
por: Coppola, Rosa Cristina, et al.
Publicado: (2012)

Comparison of the accelerated and classic vaccination schedules against Hepatitis B: three-week Hepatitis B vaccination schedule provides immediate and protective immunity
por: Saltoğlu, Nese, et al.
Publicado: (2003)

The war against hepatitis B: a history of the International Task Force on Hepatitis B Immunization
por: Stanton, Jennifer
Publicado: (1996)

One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors
por: Schiwon, Maren, et al.
Publicado: (2018)

Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis
por: Schulte, Rike, et al.
Publicado: (2020)

Linear B-Cell Epitopes in Human Norovirus GII.4 Capsid Protein Elicit Blockade Antibodies
por: Moeini, Hassan, et al.
Publicado: (2021)

Persistence of hepatitis B surface antibody and immune memory to hepatitis B vaccine among medical college students in Madinah
por: Mahallawi, Waleed
Publicado: (2018)

Antibody and immune memory persistence post infant hepatitis B vaccination
por: Hudu, Shuaibu A, et al.
Publicado: (2013)

Persistence of immunity to hepatitis B vaccine as infants, 17 years earlier
por: Azarkar, Zohreh, et al.
Publicado: (2018)

World Hepatitis day 2021 –screening and vaccination against Hepatitis B virus in Accra, Ghana
por: Kusi, Kwadwo Asamoah, et al.
Publicado: (2023)

Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection
por: Noordeen, Faseeha, et al.
Publicado: (2015)

Applicability of Metal Nanoparticles in the Detection and Monitoring of Hepatitis B Virus Infection
por: Shevtsov, Maxim, et al.
Publicado: (2017)

The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data
por: Velkov, Stoyan, et al.
Publicado: (2018)

Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B
por: Wang, Wenjun, et al.
Publicado: (2020)

Outcome of Antiviral Immunity in the Liver Is Shaped by the Level of Antigen Expressed in Infected Hepatocytes
por: Manske, Katrin, et al.
Publicado: (2018)

Impaired Immune Response to Primary but Not to Booster Vaccination Against Hepatitis B in Older Adults
por: Weinberger, Birgit, et al.
Publicado: (2018)

The Immune Response of Vaccination Against Hepatitis B virus in Iranian Patients Undergoing Chemotherapy
por: Meidani, Mohsen, et al.
Publicado: (2017)

Parenteral–Oral Immunization with Plant-Derived HBcAg as a Potential Therapeutic Vaccine against Chronic Hepatitis B
por: Pyrski, Marcin, et al.
Publicado: (2019)

Persistence of Anti-Hbs after up to 30 Years in Health Care Workers Vaccinated against Hepatitis B Virus
por: Cocchio, Silvia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b3cqrv05ak0mb58libvvqcadli